Pengaruh Berbagai Komposisi Media Tanam dan Pupuk Kandang terhadap Pertumbuhan dan Hasil Tanaman Daun Dewa (Gynura Pseudochina(l.)dc)

Daun dewa merupakan tanaman berkhasiat obat yang masih kurang dikenal masyarakat Indonesia khususnya masyarakat kota Palu. Tanaman ini banyak memiliki khasiat untuk pengobatan dan juga mudah untuk di budidayakan, sehingga berpotensi untuk dikembangkan. Penelitian ini bertujuan untuk mengetahui pengaruh komposisi berbagai media tanam dan jenis pupuk kandang yang tepat terhadap pertumbuhan dan hasil tanaman daun dewa. Penelitian ini dilaksanakan pada bulan Januari 2013 yang bertempat di Kelurahan Petobo Jln. Jenderal Soeharto, Kecamatan Palu Selatan, dengan ketinggian tempat kurang lebih ± 85m di atas permukaan laut (dpl). Penelitian dilaksanakan dalam bentuk percobaan yang disusun berdasarkan rancangan acak kelompok (RAK) dengan dua faktor yang terdiri atas faktor pertama adalah komposisi media yang berbeda (M) yang terdiri atas 3 (tiga) taraf perlakuan yakni M1 (1:1 (Tanah:Pasir), M2 (1:2 (Tanah:Pasir) dan M3 (2:1 (Tanah:Pasir)dan faktor kedua adalah pupuk kandang (P) yang terdiri dari 3 (tiga) taraf yakni P1 (Pupuk Kandang Ayam), P2(Pupuk Kandang Sapi) dan P3 (Pupuk Kandang Kambing). Masing-masing perlakuan diulang sebanyak tiga kali,sehingga secara keseluruhan terdapat 3 x 3 x 3 = 27 dan masing masing perlakuan terdapat 2 (dua) tanaman sehingga jumlah keseluruhan tanaman yaitu 54 tanaman. Untuk mengetahui pengaruh perlakuan terhadap parameter pengamatan, maka dilakukan analisis ragam (uji F 5%). Jika pengaruh nyata, maka dilanjutkan dengan uji DMRT 5%.Hasil penelitian menujukan bahwa perlakuan jenis pupuk kandang terbaik terdapat pada perlakuan P2 dan perlakuan komposisi media terdapat pada perlakuan M1 serta interaksi terbaik terdapat pada perlakuan P2M1 untuk variabel jumlah daun, jumlah anakan dan berat basah tajuk

Peripleo: a tool for exploring heterogenous data through the dimensions of space and time

This is the author accepted manuscript. The final version is available from Code4Lib via the URL in this record.This article introduces Peripleo, a prototype spatiotemporal search and visualization tool. Peripleo enables users to explore the geographic, temporal and thematic composition of distributed digital collections in their entirety, and then to progressively filter and drill down to explore individual records. We provide an overview of Peripleo's features, and present the underlying technical architecture. Furthermore, we discuss how datasets that differ vastly in terms of size, content type and theme can be made uniformly accessible through a set of lightweight metadata conventions we term “connectivity through common references”. Our current demo installation links approximately half a million records from 25 datasets. These datasets originate from a spectrum of sources, ranging from the small personal photo collection with 35 records, to the large institutional database with 134.000 objects. The product of research in the Andrew W. Mellon-funded Pelagios 3 project, Peripleo is Open Source software.The authors wish to thank the Andrew W. Mellon Foundation for funding this work

Identifikasi Toleransi Kekeringan Padi Gogo Lokal Tanangge Pada Berbagai Larutan Peg

Penelitian dilaksanakan di Laboratorium Ilmu dan Teknologi benih Fakultas Pertanian Untad bertujuan untuk untuk mengetahui toleransi padi gogo lokal Tanangge terhadap kekeringan. Penelitian ini dilakukan dalam bentuk percobaan menggunakan rancangan acak lengkap (RAL) dengan 5 taraf pemberian tekanan osmosis larutan Polyethylene glycol (PEG) 6000 yaitu :tanpa pemberian larutan PEG (kontrol), - 1 bar, - 2 bar, - 3 bar dan - 4 bar, setiap perlakuan diulangi sebanyak 5 kali sehingga terdapat 25 satuan percobaan. Setiap satuan percobaan menggunakan uji kertas digulung didirikan dalam plastik (UKDp) dimana setiap unit menggunakan 50 benih. Data dianalisis menggunakan analisis ragam dan perbedaan antar perlakuan yang dicobakan ditentukan dengan uji BNJ 5%. Hasil penelitian menunjukkan berpengaruh nyata terhadap semua parameter pengamatan. Uji cekaman kekeringan dengan penggunaan larutan PEG 6000 mengindikasikan padi gogo lokal Tanangge toleran terhadap kekeringan yang ditunjukkan oleh kecepatan berkecambah, waktu berkecambah, persentase kecambah normal, panjang plumula, rasio panjang akar per panjang plumula dan kandungan prolin bebas

Low intensity vibration mitigates tumor progression and protects bone quantity and quality in a murine model of myeloma

Myeloma facilitates destruction of bone and marrow. Since physical activity encourages musculoskeletal preservation we evaluated whether low-intensity vibrations (LIV), a component of mechanical signaling, could protect bone and marrow during myeloma progression. Immunocompromised-mice (n=25) were injected with human-myeloma cells, while 8 (AC) were saline-injected. Myeloma-injected mice (LIV; n=13) were subjected to daily-mechanical loading (15min/d; 0.3g @ 90Hz) while 12 (MM) were sham-handled. At 8w, femurs had 85% less trabecular bone volume (BV) fraction in MM versus AC, yet only a 21% decrease in LIV as compared to as compared to AC, reflecting a 76% increase versus MM. Cortical BV was 21% and 15% lower in MM and LIV, respectively, than AC; LIV showing 30% improvement over MM. Similar outcomes were observed in the axial skeleton, showing a 35% loss in MM with a 27% improved retention of bone in L5 of LIV-treated mice as compared to MM. Transcortical-perforations in the femur from myeloma-induced osteolysis were 9× higher in MM versus AC, reduced by 57% in LIV. Serum-TRACP5b, 61% greater in MM versus AC, rose by 33% in LIV compared to AC, a 45% reduction in activity when compared to MM. Histomorphometric analyses of trabecular bone demonstrated a 70% elevation in eroded surfaces of MM versus AC, while measures in LIV were 58% below those in MM. 72% of marrow in the femur of MM mice contained tumor, contrasted by a 31% lower burden in LIV. MM mice (42%) presented advanced-stage necrosis of marrow in the tibia while present in just 8% of LIV. Myeloma infiltration inversely correlated to measures of bone quality, while LIV slowed systemic myeloma-associated decline in bone quality and inhibited tumor progression through the hindlimbs

DQM4HEP - A Generic Online Monitor for Particle Physics Experiments

There is currently a lot of activity in R&D for future collider experiments. Multiple detector prototypes are being tested, each one with slightly different requirements regarding the format of the data to be analysed. This has generated a variety of ad-hoc solutions for data acquisition and online data monitoring. We present a generic C++11 online monitoring framework called DQM4HEP, which is designed for use as a generic online monitor for particle physics experiments, ranging from small tabletop experiments to large multi-detector testbeams, such as those currently ongoing/planned at the DESY II or CERN SPS beamlines. We present results obtained using DQM4HEP at several testbeams where the CALICE AHCAL, SDHCAL and SiWECAL detector prototypes have been tested. During these testbeams, online analysis using DQM4HEP's framework has been developed and used. We also present the currently ongoing work to integrate DQM4HEP within the EUDAQ tool. EUDAQ is a tool for common and generic data acquisition within the AIDA-2020 collaboration. This will allow these two frameworks to work together as a generic and complete DAQ and monitoring system for any type of detector prototype tested on beam tests, which is one of the goals of the AIDA-2020 project

FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors

[EN] Objectives: Reproducible association of a functional polymorphism in FCGR2A with response to a TNF inhibitor (TNFi) in patients with rheumatoid arthritis (RA) led us to explore other Fc?R functional polymorphisms. Methods: Functional polymorphisms FCGR3A F158V, FCGR2B I223T and promoter VNTR in FCGRT were analyzed in up to 429 patients with RA. Response to TNFi was recorded during standard care at 3, 6 and 12 months of follow-up. Fixed effects meta-analysis of studies addressing FCGR3A F158V polymorphism, which is the most studied of these polymorphisms, was conducted with inverse variance weighting. Results: None of the functional polymorphisms were associated with change in DAS28. Meta-analysis of the seven studies (899 patients) with available data addressing association of FCGR3A F158V with response to TNFi in RA showed no association (OR: 1.11, 95% CI: 0.8-1.5; p = 0.5). Conclusion: None of the three functional polymorphisms in Fc?R genes showed association with response to TNFi in patients with RA. These negative results were obtained in spite of the larger size of this study relative to previous studies addressing the same polymorphisms. In addition, meta-analysis of FCGR3A F158V was also negative against the results provided by previous studies

Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

Background: Patients with inflammatory bowel disease who achieve remission with anti-tumour necrosis factor (anti-TNF) drugs may have treatment withdrawn due to safety concerns and cost considerations, but there is a lack of prospective, controlled data investigating this strategy. The primary study aim is to compare the rates of clinical remission at 1?year in patients who discontinue anti-TNF treatment versus those who continue treatment. Methods: This is an ongoing, prospective, double-blind, multicentre, randomized, placebo-controlled study in patients with Crohn?s disease or ulcerative colitis who have achieved clinical remission for ?6?months with an anti-TNF treatment and an immunosuppressant. Patients are being randomized 1:1 to discontinue anti-TNF therapy or continue therapy. Randomization stratifies patients by the type of inflammatory bowel disease and drug (infliximab versus adalimumab) at study inclusion. The primary endpoint of the study is sustained clinical remission at 1?year. Other endpoints include endoscopic and radiological activity, patient-reported outcomes (quality of life, work productivity), safety and predictive factors for relapse. The required sample size is 194 patients. In addition to the main analysis (discontinuation versus continuation), subanalyses will include stratification by type of inflammatory bowel disease, phenotype and previous treatment. Biological samples will be obtained to identify factors predictive of relapse after treatment withdrawal. Results: Enrolment began in 2016, and the study is expected to end in 2020. Conclusions: This study will contribute prospective, controlled data on outcomes and predictors of relapse in patients with inflammatory bowel disease after withdrawal of anti-TNF agents following achievement of clinical remission. Clinical trial reference number: EudraCT 2015-001410-1

Measurement of the W-boson mass in pp collisions at s√=7TeV with the ATLAS detector

A measurement of the mass of the W boson is presented based on proton–proton collision data recorded in 2011 at a centre-of-mass energy of 7 TeV with the ATLAS detector at the LHC, and corresponding to 4.6 fb−1 of integrated luminosity. The selected data sample consists of 7.8×106 candidates in the W→μν channel and 5.9×106 candidates in the W→eν channel. The W-boson mass is obtained from template fits to the reconstructed distributions of the charged lepton transverse momentum and of the W boson transverse mass in the electron and muon decay channels, yielding mW=80370=80370±7 (stat.)±11(exp. syst.)±14 (mod. syst.) MeV±19MeV, where the first uncertainty is statistical, the second corresponds to the experimental systematic uncertainty, and the third to the physics-modelling systematic uncertainty. A measurement of the mass difference between the W+ and W− bosons yields mW+−mW−=−29±28 MeV

Measurement of the W-boson mass in pp collisions at s√=7TeV with the ATLAS detector

A measurement of the mass of the W boson is presented based on proton–proton collision data recorded in 2011 at a centre-of-mass energy of 7 TeV with the ATLAS detector at the LHC, and corresponding to 4.6 fb−1 of integrated luminosity. The selected data sample consists of 7.8×106 candidates in the W→μν channel and 5.9×106 candidates in the W→eν channel. The W-boson mass is obtained from template fits to the reconstructed distributions of the charged lepton transverse momentum and of the W boson transverse mass in the electron and muon decay channels, yielding mW=80370=80370±7 (stat.)±11(exp. syst.)±14 (mod. syst.) MeV±19MeV, where the first uncertainty is statistical, the second corresponds to the experimental systematic uncertainty, and the third to the physics-modelling systematic uncertainty. A measurement of the mass difference between the W+ and W− bosons yields mW+−mW−=−29±28 MeV

Measurement of the W-boson mass in pp collisions at root s=7 TeV with the ATLAS detector

A measurement of the mass of the W boson is presented based on proton–proton collision data recorded in 2011 at a centre-of-mass energy of 7 TeV with the ATLAS detector at the LHC, and corresponding to 4.6 fb−1 of integrated luminosity. The selected data sample consists of 7.8 × 106 candidates in the W → μν channel and 5.9 × 106 candidates in the W → eν channel. The W-boson mass is obtained from template fits to the reconstructed distributions of the charged lepton transverse momentum and of the W boson transverse mass in the electron and muon decay channels, yielding mW = 80370 ± 7 (stat.) ± 11(exp. syst.) ± 14 (mod. syst.) MeV = 80370 ± 19 MeV, where the first uncertainty is statistical, the second corresponds to the experimental systematic uncertainty, and the third to the physics-modelling systematic uncertainty. A measurement of the mass difference between the W+ and W− bosons yields mW+ − mW− = − 29 ± 28 MeV